Pharmacologic agents targeting autophagy.

Autophagy is an important intracellular catabolic mechanism critically involved in regulating tissue homeostasis. The implication of autophagy in human diseases and the need to understand its regulatory mechanisms in mammalian cells have stimulated research efforts that led to the development of high-throughput screening protocols and small-molecule modulators that can activate or inhibit autophagy. Herein we review the current landscape in the development of screening technology as well as the molecules and pharmacologic agents targeting the regulatory mechanisms of autophagy. We also evaluate the potential therapeutic application of these compounds in different human pathologies.

[1]  S. Sehgal,et al.  Rapamycin (AY-22,989), a new antifungal antibiotic. II. Fermentation, isolation and characterization. , 1975, The Journal of antibiotics.

[2]  S. Sehgal,et al.  Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. , 1975, The Journal of antibiotics.

[3]  Q. Yu,et al.  Modification of lysosomal proteolysis in mouse liver with taxol. , 1986, The American journal of pathology.

[4]  P. Seglen,et al.  Inhibition of autophagic-lysosomal delivery and autophagic lactolysis by asparagine , 1991, The Journal of cell biology.

[5]  D. L. Tuttle,et al.  Cytoskeletal elements are required for the formation and maturation of autophagic vacuoles , 1992, Journal of cellular physiology.

[6]  J. S. Røtnes,et al.  Dependence of hepatocytic autophagy on intracellularly sequestered calcium. , 1993, The Journal of biological chemistry.

[7]  R. Jope,et al.  Brain G-protein proteolysis by calpain: enhancement by lithium , 1994, Brain Research.

[8]  J P Schellens,et al.  The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. , 1997, European journal of biochemistry.

[9]  U. Busch,et al.  A review of drug‐induced lysosomal disorders of the liver in man and laboratory animals , 1997, Microscopy research and technique.

[10]  Y. Moriyama,et al.  Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. , 1998, Cell structure and function.

[11]  James E. Goldman,et al.  Protection against Fatal Sindbis Virus Encephalitis by Beclin, a Novel Bcl-2-Interacting Protein , 1998, Journal of Virology.

[12]  S. Schreiber.  Chemical genetics resulting from a passion for synthetic organic chemistry. , 1998, Bioorganic & medicinal chemistry.

[13]  P. Codogno,et al.  Distinct Classes of Phosphatidylinositol 3′-Kinases Are Involved in Signaling Pathways That Control Macroautophagy in HT-29 Cells* , 2000, The Journal of Biological Chemistry.

[14]  A. Tolkovsky,et al.  Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease? , 2002, Biochimie.

[15]  D. Rubinsztein,et al.  Glycogen Synthase Kinase-3β Inhibitors Prevent Cellular Polyglutamine Toxicity Caused by the Huntington's Disease Mutation* , 2002, The Journal of Biological Chemistry.

[16]  J. Vance,et al.  The Deacetylase HDAC6 Regulates Aggresome Formation and Cell Viability in Response to Misfolded Protein Stress , 2003, Cell.

[17]  Arnold J. Levine,et al.  Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Govind Bhagat,et al.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. , 2003, The Journal of clinical investigation.

[19]  Craig B. Thompson,et al.  Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes , 2004, Nature Cell Biology.

[20]  M. Matsui,et al.  In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.

[21]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[22]  Michael D. Schneider,et al.  Bcl-2 Antiapoptotic Proteins Inhibit Beclin 1-Dependent Autophagy , 2005, Cell.

[23]  D. Rubinsztein,et al.  Lithium induces autophagy by inhibiting inositol monophosphatase , 2005, The Journal of cell biology.

[24]  R. DePinho,et al.  The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin , 2005, Science.

[25]  Hiroshi Yasui,et al.  Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. , 2005, Blood.

[26]  K. Roth,et al.  Autophagy, Bafilomycin and Cell Death: The “A-B-Cs” of Plecomacrolide-Induced Neuroprotection , 2006, Autophagy.

[27]  D. Hardie.  Neither LKB1 nor AMPK are the direct targets of metformin. , 2006, Gastroenterology.

[28]  Wenqing Cai,et al.  Small molecule regulators of autophagy identified by an image-based high-throughput screen , 2007, Proceedings of the National Academy of Sciences.

[29]  J. Cleveland,et al.  Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. , 2007, Blood.

[30]  D. Andrews,et al.  Regulation of autophagy by the inositol trisphosphate receptor , 2007, Cell Death and Differentiation.

[31]  Daniel J. Klionsky,et al.  Autophagy fights disease through cellular self-digestion , 2008, Nature.

[32]  S. Akira,et al.  Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production , 2008, Nature.

[33]  C. Xing,et al.  Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901. , 2008, Acta biochimica et biophysica Sinica.

[34]  B. Rini,et al.  Temsirolimus, an Inhibitor of Mammalian Target of Rapamycin , 2008, Clinical Cancer Research.

[35]  D. Rubinsztein,et al.  Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. , 2008, Nature chemical biology.

[36]  Y. Moriyasu,et al.  Use of protease inhibitors for detecting autophagy in plants. , 2008, Methods in enzymology.

[37]  N. Mizushima,et al.  Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. , 2008, Molecular biology of the cell.

[38]  K. Shokat,et al.  Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases , 2008, Nature chemical biology.

[39]  F. Giles,et al.  Deforolimus (AP23573) a novel mTOR inhibitor in clinical development , 2008, Expert opinion on investigational drugs.

[40]  D. Sabatini,et al.  mTOR Mediated Anti-Cancer Drug Discovery. , 2009, Drug discovery today. Therapeutic strategies.

[41]  N. Buckley,et al.  Survival after Massive Hydroxychloroquine Overdose , 2009, Anaesthesia and intensive care.

[42]  P. Glynn,et al.  Desmethylclomipramine induces the accumulation of autophagy markers by blocking autophagic flux , 2009, Journal of Cell Science.

[43]  D. Sabatini,et al.  An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1* , 2009, Journal of Biological Chemistry.

[44]  E. Morselli,et al.  The inositol 1,4,5-trisphosphate receptor regulates autophagy through its interaction with Beclin 1 , 2009, Cell Death and Differentiation.

[45]  E. White,et al.  The Double-Edged Sword of Autophagy Modulation in Cancer , 2009, Clinical Cancer Research.

[46]  K. Shokat,et al.  Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. , 2010, Cancer cell.

[47]  F. Giles,et al.  Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis* , 2010, The Journal of Biological Chemistry.

[48]  L. Tsai,et al.  Negative regulation of Vps34 by Cdk mediated phosphorylation. , 2010, Molecular cell.

[49]  Markus R. Wenk,et al.  Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase* , 2010, The Journal of Biological Chemistry.

[50]  S. Baroletti,et al.  Everolimus: A Proliferation Signal Inhibitor with Clinical Applications in Organ Transplantation, Oncology, and Cardiology , 2010, Pharmacotherapy.

[51]  J. Taylor,et al.  VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD , 2010, Autophagy.

[52]  G. Bjørkøy,et al.  A reporter cell system to monitor autophagy based on p62/SQSTM1 , 2010, Autophagy.

[53]  K. Shokat,et al.  Shaping Development of Autophagy Inhibitors with the Structure of the Lipid Kinase Vps34 , 2010, Science.

[54]  R. Young,et al.  Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin* , 2010, The Journal of Biological Chemistry.

[55]  J. Taylor,et al.  HDAC6 controls autophagosome maturation essential for ubiquitin‐selective quality‐control autophagy , 2010, The EMBO journal.

[56]  細川 奈生.  Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy , 2010 .

[57]  D. Rubinsztein,et al.  Cytoprotective roles for autophagy , 2010, Current opinion in cell biology.

[58]  R. Xavier,et al.  A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. , 2010, Developmental cell.

[59]  Tao Zhang,et al.  Control of basal autophagy by calpain1 mediated cleavage of ATG5 , 2010, Autophagy.

[60]  C. Kenific,et al.  Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation , 2011, Molecular biology of the cell.

[61]  Xuejun Jiang,et al.  Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. , 2011, Molecular cell.

[62]  Miyuki Yoshida,et al.  Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799. , 2011, Bioorganic & medicinal chemistry letters.

[63]  H. Ke,et al.  Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13 , 2011, Cell.

[64]  D. Rubinsztein,et al.  Autophagy and Aging , 2011, Cell.

[65]  S. Minucci,et al.  HDACs link the DNA damage response, processing of double-strand breaks and autophagy , 2011, Nature.

[66]  Steven J Brown,et al.  Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways , 2011, Proceedings of the National Academy of Sciences.

[67]  M. Hall,et al.  Rapamycin passes the torch: a new generation of mTOR inhibitors , 2011, Nature Reviews Drug Discovery.

[68]  M. Belvin,et al.  GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway , 2011, Molecular Cancer Therapeutics.

[69]  S. Wesselborg,et al.  Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks , 2011, Molecular and Cellular Biology.

[70]  D. Rubinsztein,et al.  Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. , 2011, The Journal of clinical investigation.

[71]  Daniel J. Klionsky,et al.  Relieving Autophagy and 4EBP1 from Rapamycin Resistance , 2011, Molecular and Cellular Biology.

[72]  M. Belvin,et al.  GDC-0941, a Novel Class I Selective PI3K Inhibitor, Enhances the Efficacy of Docetaxel in Human Breast Cancer Models by Increasing Cell Death In Vitro and In Vivo , 2012, Clinical Cancer Research.

[73]  M. Imoto,et al.  Xanthohumol impairs autophagosome maturation through direct inhibition of valosin-containing protein. , 2012, ACS chemical biology.

[74]  J. Winkler,et al.  Lys05 , 2012, Autophagy.

[75]  G. Bhagat,et al.  Beclin 1 Phosphorylation Akt-Mediated Regulation of Autophagy and Tumorigenesis Through , 2012 .

[76]  D. Rubinsztein,et al.  Control of autophagy as a therapy for neurodegenerative disease , 2012, Nature Reviews Neurology.

[77]  P. Marks,et al.  Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death , 2012, Proceedings of the National Academy of Sciences.

[78]  G. Juhász.  Interpretation of bafilomycin, pH neutralizing or protease inhibitor treatments in autophagic flux experiments , 2012, Autophagy.

[79]  Shaohui Wang,et al.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin , 2012, Progress in Neurobiology.

[80]  Y. Wang,et al.  Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases. , 2013, Carcinogenesis.

[81]  M. Daly,et al.  Selective modulation of autophagy, innate immunity, and adaptive immunity by small molecules. , 2013, ACS chemical biology.

[82]  N. Grishin,et al.  EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance , 2013, Cell.

[83]  D. Rubinsztein,et al.  Therapeutic induction of autophagy to modulate neurodegenerative disease progression , 2013, Acta Pharmacologica Sinica.

[84]  Seo Yun Kim,et al.  Autophagy Inhibition with Monensin Enhances Cell Cycle Arrest and Apoptosis Induced by mTOR or Epidermal Growth Factor Receptor Inhibitors in Lung Cancer Cells , 2013, Tuberculosis and respiratory diseases.

[85]  R. Xavier,et al.  Autosis is a Na+,K+-ATPase–regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia–ischemia , 2013, Proceedings of the National Academy of Sciences.

[86]  G. Kroemer,et al.  Chaperone-mediated autophagy degrades mutant p53. , 2013, Genes & development.

[87]  J. Moscat,et al.  SQSTM1/p62 Interacts with HDAC6 and Regulates Deacetylase Activity , 2013, PloS one.

[88]  P. Codogno,et al.  Autophagy and microtubules – new story, old players , 2013, Journal of Cell Science.

[89]  T. Simmen,et al.  The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis , 2013, Oncogene.

[90]  R. Nixon,et al.  The role of autophagy in neurodegenerative disease , 2013, Nature Medicine.

[91]  D. Reinhardt,et al.  Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy , 2013, Leukemia.

[92]  J. McGee,et al.  Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability. , 2014, Carcinogenesis.

[93]  S Shoji-Kawata,et al.  [Identification of a candidate therapeutic autophagy-inducing peptide]. , 2015, Seikagaku. The Journal of Japanese Biochemical Society.